Full Text View
Tabular View
No Study Results Posted
Related Studies
Study of Lenalidomide as a Treatment for Neuropathy Associated With Monoclonal Gammopathy of Undetermined Significance (MGUS)
This study is currently recruiting participants.
Study NCT00665652   Information provided by Dartmouth-Hitchcock Medical Center
First Received: April 22, 2008   Last Updated: August 26, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Neuropathy
Additional conditions recognized in this trial
Monoclonal Gammopathies, Benign
Paraproteinemias
More general conditions related to this trial
Blood Protein Disorders
Hematologic Diseases
Hypergammaglobulinemia
Immune System Diseases
Immunoproliferative Disorders
Interventions listed in this trial
Lenalidomide
More general drug interventions related to this trial
Antineoplastic Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Dartmouth-Hitchcock Medical Center
Celgene Corporation


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services